Invention Grant
- Patent Title: Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
-
Application No.: US17105870Application Date: 2020-11-27
-
Publication No.: US11427571B2Publication Date: 2022-08-30
- Inventor: Travis Remarchuk , Anantha Sudhakar
- Applicant: DENALI THERAPEUTICS INC.
- Applicant Address: US CA South San Francisco
- Assignee: DENALI THERAPEUTICS INC.
- Current Assignee: DENALI THERAPEUTICS INC.
- Current Assignee Address: US CA South San Francisco
- Agency: McCarter & English, LLP
- Agent Xin Zhang; Paul M. Zagar
- Main IPC: C07D403/12
- IPC: C07D403/12 ; A61P25/28 ; A61K9/20
Abstract:
The present disclosure relates to crystalline polymorph and amorphous forms of 2-methyl-2-(3-methyl-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-1H-pyrazol-1-yl)propanenitrile or solvates, tautomers, and pharmaceutically acceptable salts or cocrystals thereof, and processes for their preparation.
Public/Granted literature
- US20210087176A1 POLYMORPHS AND SOLID FORMS OF A PYRIMIDINYLAMINO-PYRAZOLE COMPOUND, AND METHODS OF PRODUCTION Public/Granted day:2021-03-25
Information query
